IL123884A - 6-formylpterin derivatives and oligomers and polymers thereof, for use as active oxygen scavengers - Google Patents

6-formylpterin derivatives and oligomers and polymers thereof, for use as active oxygen scavengers

Info

Publication number
IL123884A
IL123884A IL12388497A IL12388497A IL123884A IL 123884 A IL123884 A IL 123884A IL 12388497 A IL12388497 A IL 12388497A IL 12388497 A IL12388497 A IL 12388497A IL 123884 A IL123884 A IL 123884A
Authority
IL
Israel
Prior art keywords
compound
formula
active oxygen
derivative
hydrogen atom
Prior art date
Application number
IL12388497A
Other languages
English (en)
Other versions
IL123884A0 (en
Original Assignee
Cmic Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cmic Co Ltd filed Critical Cmic Co Ltd
Publication of IL123884A0 publication Critical patent/IL123884A0/xx
Publication of IL123884A publication Critical patent/IL123884A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12388497A 1996-07-31 1997-07-30 6-formylpterin derivatives and oligomers and polymers thereof, for use as active oxygen scavengers IL123884A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21804396 1996-07-31
PCT/JP1997/002649 WO1998004558A1 (fr) 1996-07-31 1997-07-30 Piegeurs d'oxygene actifs a base de derives de pterine

Publications (2)

Publication Number Publication Date
IL123884A0 IL123884A0 (en) 1998-10-30
IL123884A true IL123884A (en) 2002-04-21

Family

ID=16713759

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12388497A IL123884A (en) 1996-07-31 1997-07-30 6-formylpterin derivatives and oligomers and polymers thereof, for use as active oxygen scavengers

Country Status (10)

Country Link
US (1) US6162806A (zh)
EP (1) EP0884317B1 (zh)
KR (1) KR19990063880A (zh)
CN (1) CN1084332C (zh)
AT (1) ATE295847T1 (zh)
AU (1) AU739069B2 (zh)
DE (1) DE69733308D1 (zh)
IL (1) IL123884A (zh)
NZ (1) NZ330078A (zh)
WO (1) WO1998004558A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
WO2000039129A1 (en) * 1998-12-28 2000-07-06 K.U. Leuven Research & Development Immunosuppressive effects of pteridine derivatives
PL3138566T3 (pl) 2003-11-17 2022-03-07 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii z użyciem bh4
WO2006055511A2 (en) 2004-11-17 2006-05-26 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
JP2010515747A (ja) * 2007-01-12 2010-05-13 ビオマリン プハルマセウトイカル インコーポレイテッド テトラヒドロビオプテリンプロドラッグ
KR100882340B1 (ko) * 2007-03-30 2009-02-11 주식회사 래디안 테리딘이 유효성분으로 포함된 나노리포좀 함유 화장료 조성물 및 그 제조방법
ES2524026T3 (es) * 2008-01-03 2014-12-03 Biomarin Pharmaceutical Inc. Análogo de pterina para tratar una afección que responde a BH4
EP2582712A4 (en) 2010-06-18 2013-12-04 Us Health USEFUL LIQUID PURINE-PTERINATED HPPK INHIBITORS AS ANTIBACTERIAL AGENTS
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
US10316167B2 (en) * 2014-09-19 2019-06-11 Plastipak Packaging Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
EP3722297A1 (en) 2015-03-04 2020-10-14 Gilead Sciences, Inc. Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
AU2017318601B2 (en) 2016-09-02 2020-09-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
US11091509B2 (en) 2016-10-11 2021-08-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HPPK inhibitors useful as antibacterial agents
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994303A (en) * 1988-03-21 1991-02-19 Garlock, Inc. Fiber impregnation process
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
DE4418096A1 (de) * 1994-05-24 1995-11-30 Cassella Ag Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase
ATE218345T1 (de) * 1994-08-05 2002-06-15 Suntory Ltd Arzneimittel gegen spinocerebellare degeneration
WO1998008516A1 (fr) * 1996-08-30 1998-03-05 Suntory Limited Preparations servant a la prevention et au traitement de maladies provoquees par une hypofonction de l'oxyde nitrique synthase

Also Published As

Publication number Publication date
EP0884317B1 (en) 2005-05-18
AU3707197A (en) 1998-02-20
AU739069B2 (en) 2001-10-04
EP0884317A4 (en) 1999-04-14
EP0884317A2 (en) 1998-12-16
IL123884A0 (en) 1998-10-30
NZ330078A (en) 2000-01-28
US6162806A (en) 2000-12-19
CN1084332C (zh) 2002-05-08
DE69733308D1 (de) 2005-06-23
WO1998004558A1 (fr) 1998-02-05
CN1198161A (zh) 1998-11-04
ATE295847T1 (de) 2005-06-15
KR19990063880A (ko) 1999-07-26

Similar Documents

Publication Publication Date Title
EP0884317B1 (en) Active oxygen scavengers containing pterin derivatives
KR100220338B1 (ko) 이미다졸을 함유하는 피부보호 조성물
ES2497716T3 (es) Composiciones para utilizar en métodos destinados a tratar la pérdida auditiva
FR2577805A1 (fr) Composition de traitement de la peau a base de glucoside d'hydroquinone
PT98512A (pt) Processo para a preparacao de composicoes para o tratamento da pele contendo retinoides
JP3822479B2 (ja) 還元型補酵素ｑ水溶液の安定化組成
ES2202665T3 (es) Extracto de tejido inflamatorio como supresor de la producccion de monoxido de carbono.
US7314633B2 (en) Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
US5399573A (en) Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract
EP0612733B1 (en) Use of 5-amino-Phthaloylhydrazide as Anti-Hypoxic and defensive Agent
EP3453704B1 (en) Phenol compound and combination of same with a benzodiazepine fused to 1,4-dihydropyridine for treating diseases of the central nervous and vascular systems
RU2328281C2 (ru) Местная готовая препаративная форма, содержащая кетопрофен, стабилизированный сулисобензоном
EP1613300B1 (en) Photostabilized topical formulations of ketoprofen containing two uv filters
CA2233312C (en) Active oxygen scavengers containing pterin derivatives
ES2237625T3 (es) Uso de un derivado de hidantoina en una composicion farmaceutica contra la hipoalbuminemia.
US20100022604A1 (en) Prophylactic or therapeutic agent for alopecia
KR100514009B1 (ko) 1,2,4-벤조트리아진옥사이드제제
US4391809A (en) Methods for treating psoriasis
US5981538A (en) Methods of treating psoriasis employing substituted azaspiranes
KR20050108402A (ko) 만성 피부 질환의 치료제 및/또는 예방제
JPH072676A (ja) 医薬品および／または化粧品調製剤
EP0439187A2 (en) Antioxidant composition in vivo comprising enol form delta-lactone of diketogulonic acid
KR20230000400A (ko) 산소 기체 서방형 나노 에멀젼 조성물 및 이의 제조방법
KR20230000401A (ko) 치아 미백용 나노 에멀젼 조성물 및 이의 제조방법
CA2030181A1 (en) Therapeutic agent for central nervous diseases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees